Nursing care
Apixaban: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Apixaban (Eliquis) is a direct factor Xa inhibitor given twice daily for stroke prevention in atrial fibrillation and for VTE prophylaxis and treatment. No INR or routine coagulation monitoring is needed. A missed dose is taken only if remembered the same day; a reversal agent exists but many hospitals do not stock it.
What it does and why it is prescribed
Apixaban is a direct oral anticoagulant that inhibits factor Xa directly, without requiring antithrombin as a cofactor the way heparin does. It is prescribed for stroke and systemic embolism prevention in non-valvular atrial fibrillation, and for prevention and treatment of deep vein thrombosis and pulmonary embolism.
It has a rapid onset, reaching peak effect within a few hours, and a relatively short half-life compared with warfarin. This is part of why it is dosed twice daily rather than once, and why its anticoagulant effect declines faster after a missed or stopped dose than warfarin's would.
Nursing considerations before giving it
Confirm renal function and body weight, since dose adjustment criteria for atrial fibrillation typically depend on age, weight, and serum creatinine. Review the medication list for other anticoagulants, antiplatelet agents, and strong inhibitors or inducers of CYP3A4 and P-glycoprotein, which can meaningfully raise or lower drug levels.
Ask about any planned procedures or surgery, since apixaban is usually stopped 24 to 48 hours beforehand depending on bleeding risk and renal function, and confirm this timing with the prescriber rather than assuming a standard interval. There is no need to check baseline coagulation studies before starting, since dosing is fixed and not titrated to a lab value.
What to monitor
There is no INR to monitor with apixaban, and routine coagulation tests such as PT or aPTT are not reliable indicators of its anticoagulant effect. Monitoring is largely clinical: watch for bruising, bleeding gums, blood in stool or urine, and signs of occult bleeding such as unexplained fatigue or a falling haemoglobin.
Periodically reassess renal function, since apixaban has a partial renal clearance component and declining kidney function can raise drug exposure over time even without a dose change being flagged. Anti-Xa assays calibrated specifically for apixaban exist but are used selectively, such as before urgent surgery or in suspected overdose, not as routine monitoring.
Side effects versus adverse effects
Expected effects include easy bruising and mild, self-limiting bleeding such as occasional gum bleeding on brushing, which is a known consequence of any anticoagulant and usually not a reason to stop therapy on its own.
Adverse effects requiring urgent action include major gastrointestinal bleeding, intracranial haemorrhage, and any bleeding accompanied by haemodynamic instability. Signs of stroke or systemic embolism despite therapy also warrant urgent review, since they suggest the drug is not providing adequate protection in that patient.
What to hold for and when to call
Hold apixaban and call the prescriber for any sign of major bleeding, a scheduled invasive procedure without confirmed hold instructions, or new neurological symptoms suggesting intracranial bleeding or stroke. Confirm renal function results before continuing therapy if there is any suspicion of acute kidney injury.
For minor bleeding such as a small bruise or brief gum bleeding, continued monitoring rather than automatic escalation is usually appropriate, but document it and inform the prescriber at the next review. Andexanet alfa is an approved reversal agent for factor Xa inhibitors, but it is expensive and many hospitals do not stock it, so severe bleeding is more often managed with supportive care and, where available, prothrombin complex concentrate rather than assuming a specific reversal agent is on hand.
Patient teaching
Teach patients to take apixaban twice daily, roughly twelve hours apart, with or without food, and not to stop it without speaking to their prescriber, since abrupt discontinuation raises thrombotic risk. Explain there is no routine blood test to check, unlike warfarin, so they will not have regular INR checks.
Give a clear, specific rule for a missed dose: take it as soon as remembered on the same day, then resume the normal twice-daily schedule. If it is not remembered until the next day, skip the missed dose entirely rather than doubling up. Tell them to carry information about their anticoagulant, avoid activities with high bleeding risk without discussing it first, and seek urgent care for a head injury, black or bloody stools, or bleeding that will not stop.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Does apixaban require INR monitoring?
No. Apixaban does not require INR or routine PT and aPTT monitoring, since these tests do not reliably reflect its anticoagulant effect. Dosing is fixed based on age, weight, and renal function rather than titrated to a coagulation result.
What should a patient do if they miss a dose of apixaban?
If remembered on the same day, take the missed dose as soon as possible and resume the normal twice-daily schedule. If it is not remembered until the following day, skip the missed dose and do not double up to make up for it.
Is there a reversal agent for apixaban?
Yes, andexanet alfa is approved to reverse factor Xa inhibitors including apixaban in cases of life-threatening bleeding. However, it is costly and not stocked by every hospital, so severe bleeding is frequently managed with supportive measures and other haemostatic agents where andexanet alfa is unavailable.
Why is apixaban dosed twice a day instead of once?
Apixaban has a relatively short half-life compared with other oral anticoagulants such as warfarin, so twice-daily dosing keeps drug levels more consistent and maintains steady anticoagulant coverage across the day.
More on pharmacology
Guides on this